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On the therapy of constipation, there are few reports that surveyed the actual circumstance of patients taking laxa-
tives and the eŠectiveness of the drug. In this study, we investigated the contents in prescription, the actual conditions of
administration of laxatives, and the subjective symptoms of inpatients in all wards of Kanazawa University hospital
(2000. 12. 1～2000. 12. 10). As a result of the investigation, the percentage of patients prescribed some laxatives was
found to be about 31.5％(274) of all hospitalized patients (871), and among them about 16％(43) of the patients had
some problems in defecation control. One of the causes leading to the problems for some patients (11) among them
seemed to be due to the lesser amount of magnesium oxide takenper day. Then, in the ophthalmology ward we further
investigated the proper use of laxatives and the defecation condition of the patient using a questionnaire paper and a
record paper (20 cases). Patients became constipated by hospitalization, and although being administered some laxa-
tives, they were often insu‹cient to control the defecation. Some patients (7) with changeable defecation control could
be improved by change or addition of prescription. Pharmacist concerned 5 cases of patients with change or addition of
prescription. This study indicates that pharmacists should actively oŠer information and rational usage of laxatives to
doctors and patients.
















































日付 / / /



















り添付文書では 1日 0.5―1.0 gとなっている．しか





























Fig. 1. Constipation Classiˆcation of Patients with Some Problems in Defecation Control
□: Surgical (n＝20), ■: Internal (n＝23).
Table 2. The Use of Laxatives and Management for Patients
with Some Problems in Defecation Control
Patient
population
Dosage and administration is prescribed as
labeled 11
Dosage and administration is not prescribed as
labeled 32
Take laxatives as prescribed 18
Control laxatives by himself or by nurse 17
Take laxatives which is not prescribed 4
Unknown 4
Patients with some problems in the defecation control were the 43 per-
sons, among patients who entered the Kanazawa University Hospital dur-

















































Fig. 2. Dose of Magnesium Oxide for Patients in All Inpatient Wards (n＝192)










の内訳は，1.2 g→2 g（1名），2 g→3 g（1名），1 g
→1.5 g（2名），1 g→1.5 g→2 g（1名）であり，初
回量から約 1.5倍増量していた．減量した症例はな
かった．問題のあることの原因の 1つに，酸化マグ



























◯３入院期間別 入院期間が 10日以上 1ヵ月未
満の患者 12名のうち，排便コントロールが順調な























































患者 T.N. 男 46歳
診断名 糖尿病性網膜症
既往歴 糖尿病，腹痛，高血圧
服用薬 ノルバスク（5）1 T 1×朝食後，エー
































◯高血圧 ◯糖尿病 不整脈 喘息 その他：
名前：T.N 眼科 科 性別：◯男・女 年齢：46歳
日付 9月 29日 9月 30日 10月 1日 10月 2日 10月 3日 10月 4日 10月 5日 10月 6日 10月 7日 10月 8日
お通じのあった回数をお
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ウム 2.0 g 3×毎食後に処方変更となり，
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